RATIONALE: Mutations in myosin heavy chain (MYH11) cause autosomal dominant inheritance of thoracic aortic aneurysms and dissections. At the same time, rare, nonsynonymous variants in MYH11 that are predicted to disrupt protein function but do not cause inherited aortic disease are common in the general population and the vascular disease risk associated with these variants is unknown. OBJECTIVE: To determine the consequences of the recurrent MYH11 rare variant, R247C, through functional studies in vitro and analysis of a knock-in mouse model with this specific variant, including assessment of aortic contraction, response to vascular injury, and phenotype of primary aortic smooth muscle cells (SMCs). METHODS AND RESULTS: The steady state ATPase activity (actin-activated) and the rates of phosphate and ADP release were lower for the R247C mutant myosin than for the wild-type, as was the rate of actin filament sliding in an in vitro motility assay. Myh11(R247C/R247C) mice exhibited normal growth, reproduction, and aortic histology but decreased aortic contraction. In response to vascular injury, Myh11(R247C/R247C) mice showed significantly increased neointimal formation due to increased SMC proliferation when compared with the wild-type mice. Primary aortic SMCs explanted from the Myh11(R247C/R247C) mice were dedifferentiated compared with wild-type SMCs based on increased proliferation and reduced expression of SMC contractile proteins. The mutant SMCs also displayed altered focal adhesions and decreased Rho activation, associated with decreased nuclear localization of myocardin-related transcription factor-A. Exposure of the Myh11(R247C/R247C) SMCs to a Rho activator rescued the dedifferentiated phenotype of the SMCs. CONCLUSIONS: These results indicate that a rare variant in MYH11, R247C, alters myosin contractile function and SMC phenotype, leading to increased proliferation in vitro and in response to vascular injury.
RATIONALE: Mutations in myosin heavy chain (MYH11) cause autosomal dominant inheritance of thoracic aortic aneurysms and dissections. At the same time, rare, nonsynonymous variants in MYH11 that are predicted to disrupt protein function but do not cause inherited aortic disease are common in the general population and the vascular disease risk associated with these variants is unknown. OBJECTIVE: To determine the consequences of the recurrent MYH11 rare variant, R247C, through functional studies in vitro and analysis of a knock-in mouse model with this specific variant, including assessment of aortic contraction, response to vascular injury, and phenotype of primary aortic smooth muscle cells (SMCs). METHODS AND RESULTS: The steady state ATPase activity (actin-activated) and the rates of phosphate and ADP release were lower for the R247C mutant myosin than for the wild-type, as was the rate of actin filament sliding in an in vitro motility assay. Myh11(R247C/R247C) mice exhibited normal growth, reproduction, and aortic histology but decreased aortic contraction. In response to vascular injury, Myh11(R247C/R247C) mice showed significantly increased neointimal formation due to increased SMC proliferation when compared with the wild-type mice. Primary aortic SMCs explanted from the Myh11(R247C/R247C) mice were dedifferentiated compared with wild-type SMCs based on increased proliferation and reduced expression of SMC contractile proteins. The mutant SMCs also displayed altered focal adhesions and decreased Rho activation, associated with decreased nuclear localization of myocardin-related transcription factor-A. Exposure of the Myh11(R247C/R247C) SMCs to a Rho activator rescued the dedifferentiated phenotype of the SMCs. CONCLUSIONS: These results indicate that a rare variant in MYH11, R247C, alters myosin contractile function and SMC phenotype, leading to increased proliferation in vitro and in response to vascular injury.
Authors: M J Hendzel; Y Wei; M A Mancini; A Van Hooser; T Ranalli; B R Brinkley; D P Bazett-Jones; C D Allis Journal: Chromosoma Date: 1997-11 Impact factor: 4.316
Authors: Limin Zhu; Roger Vranckx; Philippe Khau Van Kien; Alain Lalande; Nicolas Boisset; Flavie Mathieu; Mark Wegman; Luke Glancy; Jean-Marie Gasc; François Brunotte; Patrick Bruneval; Jean-Eric Wolf; Jean-Baptiste Michel; Xavier Jeunemaitre Journal: Nat Genet Date: 2006-01-29 Impact factor: 38.330
Authors: Dongxiao Shen; Jian Li; John J Lepore; Thomas J T Anderson; Sumita Sinha; Alexander Y Lin; Lan Cheng; Ethan David Cohen; Jesse D Roberts; Shoukat Dedhar; Michael S Parmacek; Robert E Gerszten Journal: Circ Res Date: 2011-07-21 Impact factor: 17.367
Authors: Eiji Isotani; Gang Zhi; Kim S Lau; Jian Huang; Yusuke Mizuno; Anthony Persechini; Ramaz Geguchadze; Kristine E Kamm; James T Stull Journal: Proc Natl Acad Sci U S A Date: 2004-04-07 Impact factor: 11.205
Authors: Wei Li; Qingle Li; Yang Jiao; Lingfeng Qin; Rahmat Ali; Jing Zhou; Jacopo Ferruzzi; Richard W Kim; Arnar Geirsson; Harry C Dietz; Stefan Offermanns; Jay D Humphrey; George Tellides Journal: J Clin Invest Date: 2014-01-09 Impact factor: 14.808
Authors: Hailong Lu; Patricia M Fagnant; Carol S Bookwalter; Peteranne Joel; Kathleen M Trybus Journal: Proc Natl Acad Sci U S A Date: 2015-07-07 Impact factor: 11.205
Authors: M Gabriela Espinosa; William S Gardner; Lisa Bennett; Bradley A Sather; Hiromi Yanagisawa; Jessica E Wagenseil Journal: J Biomech Eng Date: 2014-02 Impact factor: 2.097
Authors: Adam J Brownstein; Bulat A Ziganshin; Helena Kuivaniemi; Simon C Body; Allen E Bale; John A Elefteriades Journal: Aorta (Stamford) Date: 2017-02-01
Authors: Eimear Kennedy; Ciaran J Mooney; Roya Hakimjavadi; Emma Fitzpatrick; Shaunta Guha; Laura E Collins; Christine E Loscher; David Morrow; Eileen M Redmond; Paul A Cahill Journal: Cell Tissue Res Date: 2014-07-04 Impact factor: 5.249